-
Gabapentin-induced severe myoclonus in a patient with impaired renal function
-
Gait Dysfunction in Blepharospasm
-
Gait impairment as predictor of falls in patients with early Parkinson’s disease
-
Gait Improvement in Pegzilarginase-treated Patients With Arginase 1 Deficiency: A Blinded Kinematic Analysis
-
Gait instability and dynamic Balance Characteristics in Behavioral variant Frontotemporal dementia: A cross sectional study.
-
GALLIC ACID AMELIORATES THE NEUROBEHAVIOURAL DEFICITS INDUCED BY BISPHENOL A (BPA) IN WISTAR RATS
-
GASTROINTESTINAL SYMPTOMS ARE ASSOCIATED WITH LEFT PREDOMINANT DOPAMINE TRANSPORTER BINDING DEFICIT IN PARKINSON´S DISEASE
-
GBA Mutation Accumulates Higher Alpha-Synuclein in Alpha-Synucleinopathies
-
GBA variants in a multi-ethnic Parkinson’s disease (PD) cohort in Malaysia
-
Gender bias in patients with Parkinson’s disease undergoing subthalamic stimulation
-
Genetic factors associated with dementia in Parkinson’s disease in the Parkinson’s Incidence Cohorts Collaboration (PICC)
-
Genetic features and long-term outcome of Korean patients with Huntington’s disease.
-
Genetic hypokinetic rigid syndrome: Clinical phenotypes from infancy to adolescence in a series of Chilean Patients
-
Genotype-Phenotype Correlations in Niemann-Pick Disease Type C
-
Genotype-phenotype relations for GBA as a Parkinson’s disease risk factor gene: MDSGene Systematic Review
-
Genotypic and phenotypic spectrum of PINK-1 associated parkinsonism in 44 mutation carriers from 11 Tunisian families
-
Global access to Parkinson’s disease treatment
-
Glucocerebrosidase activity does not predict Parkinson’s Disease risk or severity
-
Gluten-induced ataxia: a misdiagnosed cause of sporadic ataxia. A case report
-
GNAO1 related movement disorders: 2 longitudinally-followed cases
-
GP2: training the next generation of Parkinson’s disease genetics researchers – wherever they are in the world
-
GPi DBS for refractory dystonia 4 years after STN DBS on a Parkinson’s Disease patient
-
GPi-DBS for KMT2B-associated dystonia: systematic review and meta-analysis
-
Gut bacterial tyrosine decarboxylase as a predictive biomarker to identify Parkinson’s disease patients with motor fluctuations requiring frequent levodopa administration
-
Gut dysbiosis in Parkinson’s disease with motor complications
-
Gut microbiota and nutritional profiles of Parkinson’s disease patients.
-
Gut microbiota in patients with Parkinson’s disease (PD) predicts disease progression better than clinical features
-
Gut, nasal and oral dysbiosis in Parkinson’s disease
MDS Virtual Congress 2021
September 17-22, 2021. Virtual Congress. www.mdscongress.org